The Insides Co. Launches The Insides Channel for Separated Ostomy and Fistula

Source：The Insides Company Limited

On：1 April 2025

Organisation：The Insides Company Limited

‍

The Insides Company is pleased to launch of The Insides Channel, an innovative product that works with The Insides System, to enable chyme reinfusion therapy in patients that have one or more separated stomas or fistulas.

This new product opens access to chyme reinfusion therapy as a key treatment option for these patients. Prior to this it was technically challenging due to the extensive amount of custom ostomy appliance modification required.

The Insides Channel solves this by simply and cleanly enabling bag-to-bag transfer of chyme to create a closed circuit between the proximal and distal small intestine.

At launch, the Insides Channel is compatible with the following ostomy appliances：

‍

• Eakin Dot 1-Piece Convex High Output

• Coloplast Sensura Mio High Output

• Eakin Dot Bung Closure Wound Pouches

‍

‍

‍

‍

‍

‍

‍

‍

‍

‍

‍

‍

‍

This innovative product aligns with The Insides Company’s mission to provide global access to chyme reinfusion therapy, ensuring patients can access its life-saving clinical benefits.

The Insides Channel is now available, along with the recently launched version 5 of The Insides System.

‍

‍

‍

About The Insides Company

The Insides Company is a leading provider of automated chyme reinfusion solutions for the therapeutic treatment of intestinal failure that has resulted from either a high-output enterocutaneous fistula or enterostomy.

‍

Contacts

The Insides® Company Limited

Garth Sutherland, CEO

Phone：+64 9 887 9309

Email：sales@theinside.co

‍